US Broker Ratings

Merit Medical Systems (MMSI): Investment Potential with 19.63% Upside and Strong Buy Ratings

Merit Medical Systems, Inc. (NASDAQ: MMSI), a key player in the healthcare sector specializing in medical instruments and supplies, is currently capturing the interest of investors with its robust growth..

Bruker Corporation (BRKR) Stock Analysis: Eyeing a 19.3% Upside Potential with Strong Buy Ratings

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, particularly in the medical devices industry, is drawing considerable attention from investors. As of now, Bruker’s market capitalization stands..

Tempus AI, Inc. (TEM) Stock Analysis: Healthcare Innovator with 89.60% Revenue Growth and Strategic Partnerships

Tempus AI, Inc. (NASDAQ: TEM), a prominent player in the healthcare technology sector, has been making waves with its cutting-edge solutions in health information services. The company, headquartered in Chicago,..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Exploring a Potential Upside of 69% Amid Robust Buy Ratings

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands as a formidable player in the biotechnology industry, focusing on the development and commercialization of therapies for rare and life-threatening diseases. With a market..

Guardant Health, Inc. (GH) Stock Analysis: A Precision Oncology Leader with Robust Growth Prospects

Guardant Health, Inc. (NASDAQ: GH) stands out in the healthcare sector as a leading player in the diagnostics and research industry, particularly in the realm of precision oncology. With a..

AptarGroup, Inc. (ATR) Stock Analysis: Potential 41% Upside with Strong Buy Ratings

AptarGroup, Inc. (NYSE: ATR), a leading player in the healthcare sector’s medical instruments and supplies industry, is capturing investor attention with an enticing potential upside of 41%. With a robust..

Alcon Inc. (ALC) Stock Analysis: Exploring a 28.74% Potential Upside in Eye Care Innovation

Alcon Inc. (NYSE: ALC), a global leader in eye care products, is drawing attention from investors with its promising 28.74% potential upside, according to analyst ratings. As a prominent player..

Sarepta Therapeutics (SRPT) Stock Analysis: A Biotech Player with a 68.40% Revenue Growth Surge

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a key player in the biotechnology sector, has captured considerable attention in the healthcare industry with its innovative approach to treating rare diseases. With a..

RadNet, Inc. (RDNT) Stock Analysis: Strong Buy Ratings Propel Investor Confidence Despite Valuation Challenges

RadNet, Inc. (NASDAQ: RDNT) is catching the attention of investors in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $5.86 billion, this Los..

Cencora, Inc. (COR) Stock Analysis: A Healthcare Giant with Robust Revenue Growth and High ROE

Cencora, Inc. (NYSE: COR), a formidable player in the healthcare sector, operates within the medical distribution industry. With a market capitalization of $65.49 billion, it stands as a pivotal entity..

STERIS plc (STE) Stock Analysis: Strong Buy Ratings and 15% Upside Potential

For investors seeking opportunities in the healthcare sector, STERIS plc (NYSE: STE) presents an intriguing option. As a global leader in infection prevention solutions, STERIS operates with a market capitalization..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Exploring a Robust 12.99% Potential Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a formidable player in the biotechnology sector, has been capturing investor attention with its promising pipeline and solid market performance. With a market capitalization of..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring an 18% Upside Potential

Investors keeping a close eye on the healthcare sector may find GE HealthCare Technologies Inc. (NYSE: GEHC) a compelling addition to their portfolios, given the company’s promising potential upside of..

Alkermes plc (ALKS) Stock Analysis: Uncovering a 43% Potential Upside in Healthcare Innovation

Alkermes plc (NASDAQ: ALKS), a leading player in the healthcare sector, presents a compelling investment opportunity with a potential upside of 43.32% according to recent analyst ratings. Specializing in the..

Ionis Pharmaceuticals (IONS) Stock Analysis: Navigating the 10.57% Upside Potential for Biotech Investors

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands out in the biotechnology sector with a market cap of $12.03 billion, showcasing its robust presence in the healthcare industry. Based in Carlsbad, California,..

West Pharmaceutical Services (WST) Stock Analysis: A 24.36% Potential Upside in the Healthcare Sector

West Pharmaceutical Services, Inc. (NYSE: WST) is a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $20.29 billion, West..

Inspire Medical Systems (INSP) Stock Analysis: Unveiling a Potential 62.87% Upside in the Medical Device Market

Inspire Medical Systems, Inc. (NASDAQ: INSP), a pioneer in the healthcare sector, is making waves with its innovative solutions for obstructive sleep apnea (OSA). Headquartered in Golden Valley, Minnesota, the..

ICON plc (ICLR) Investor Outlook: Exploring a 21% Upside with Strong Buy Ratings

ICON plc (NASDAQ: ICLR), a leader in the healthcare sector specializing in diagnostics and research, is a name that might catch your eye, especially given its current market cap of..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Riding a 17% Potential Upside Wave

For investors with an eye on the healthcare sector, iRhythm Technologies, Inc. (NASDAQ: IRTC) presents an intriguing opportunity. With a market cap of $6.03 billion, this San Francisco-based company is..

Haleon plc (HLN) Stock Analysis: Unpacking the 24.70% Upside Potential and Analyst Ratings

Haleon plc (HLN), a prominent player in the healthcare sector, is making waves in the investment community with a compelling potential upside of 24.70%, according to current analyst ratings. This..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds